Showing 4701-4710 of 5910 results for "".
- Lighthouse Guild Starts Construction on New Technology Centerhttps://modernod.com/news/lighthouse-guild-starts-construction-on-new-technology-center/2479265/Lighthouse Guild has started construction on a Technology Center that will be the largest, premier assistive technology resource in the United States, according to a news release. Designed for people who are visually impaired and for all people who are using technology in order to help them, it i
- Scientists Use Video Games to Shed Light on the Link Between Motor Activity and Visionhttps://modernod.com/news/scientists-use-video-games-to-shed-light-on-the-link-between-motor-activity-and-vision/2479266/It’s a well established fact—and intuitive truth—that vision guides movement, and that information flows readily from the visual cortex to motor centers. However, the inverse relation is far less well understood. Does engaging in movement affect how our vision is processed? Three researchers from
- VSY Biotechnology Announces Launch of the Enova C Haptic Model IOLhttps://modernod.com/news/vsy-biotechnology-announces-launch-of-the-enova-c-haptic-model-iol/2479260/VSY Biotechnology announced the launch of the Enova C Haptic Model IOL. Enova is the first and only 100% glistening-free, dry-packed hydrophobic acrylic IOL, according to VSY Biotechnology. The lens requires no warming or special conditioning before surgery. The composition of Enova mater
- Avellino Launches AvaGen as First Genetic Test to Quantify Keratoconus Risk and Presence of Corneal Dystrophieshttps://modernod.com/news/avellino-launches-avagen-as-first-genetic-test-to-quantify-keratoconus-risk-and-presence-of-corneal-dystrophies/2479255/Avellino Lab USA announced full nationwide availability in the US of AvaGen, as the first genetic test that helps determine a patient’s risk of keratoconus and the presence of other corneal dystrophies. The test allows for more confident management and treatment for patients with these conditions
- Bausch Health And Clearside Biomedical Announce FDA Filing Acceptance For Xiperehttps://modernod.com/news/bausch-health-and-clearside-biomedical-announce-fda-filing-acceptance-for-xipere/2479252/Bausch Health Companies and Bausch + Lomb, along with Clearside Biomedical, announced that the FDA has accepted the resubmitted new drug application for Xipere (triamcinolone acetonide suprachoroidal injectable suspension). FDA determined that the filing is a Class 2 resubmission and therefore as
- GenSight Biologics Announces Publication of Indirect Comparison Showing Treatment Effect of Lumevoq Versus Natural Historyhttps://modernod.com/news/gensight-biologics-announces-publication-of-indirect-comparison-showing-treatment-effect-of-lumevoq-versus-natural-history/2479249/GenSight Biologics announced that the journal Frontiers in Neurology has published results of the indirect comparison of the evolution of visual outcomes in patients treated with Lumevoq gene therapy with the spontaneous evolution in natural history (NH) studies of Leber hereditary optic
- iHealthScreen Announces CE Certification for iPredict Automated AI Systemhttps://modernod.com/news/ihealthscreen-announces-ce-mark-for-ipredict-automated-ai-system-for-early-diagnosis-of-dr-amd-and-glaucoma-suspect/2479244/iHealthScreen announced that it is the first company in the US to receive a CE certification for simultaneous diagnosis of diabetic retinopathy (DR), age related macular degeneration (AMD), and glaucoma suspect screening, according to a company news release. Using the iPredict System,
- Scientists: New Research May Revolutionize Cataract Treatmenthttps://modernod.com/news/scientists-new-research-may-revolutionize-cataract-treatment/2479235/Eye experts have made a breakthrough that could potentially change the way cataracts are treated – with potential for drug therapy to replace surgery. A team of international scientists, led by Professor Barbara Pierscionek of Anglia Ruskin University (ARU), has published
- Heru Series A Funding Accelerates Cloud and AI-Enabled Wearable Vision Diagnosis and Therapyhttps://modernod.com/news/heru-series-a-funding-accelerates-cloud-and-ai-enabled-wearable-vision-diagnosis-and-therapy/2479231/Heru, developer of wearable AI-powered vision diagnostics and augmentation software, closed its Series A financing of $30 million to advance the company’s eye diagnostic and vision correction technology platform. Originating as a spinout from Bascom Palmer Eye Institute, the Series A follo
- MedOne Surgical Receives FDA Clearance for its MicroDose Injectorhttps://modernod.com/news/medone-surgical-receives-fda-clearance-for-its-microdose-injector/2479227/MedOne Surgical announced the FDA 510(k) clearance of its MicroDose Injector device for low volume ophthalmic injections into the subretinal space. The pneumatically driven syringe system allows the surgeon to utilize a pneumatic air source, such as a vitrectomy system, to deliver a low volume in